4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-039717
President & CEO sold 130,000 shares at an average $49.52 ($6,438,036)
- President & CEO acquired 130,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2018-06-25 | Option exercise | +43,334 | $10.69 | $463,240 | 267,690 | D |
| ROBIN HOWARD W President & CEO | 2018-06-25 | Sale | −43,334 | $51.82 | $2,245,568 | 224,356 | D |
| ROBIN HOWARD W President & CEO | 2018-06-26 | Option exercise | +43,333 | $10.69 | $463,230 | 267,689 | D |
| ROBIN HOWARD W President & CEO | 2018-06-26 | Sale | −43,333 | $49.36 | $2,138,917 | 224,356 | D |
| ROBIN HOWARD W President & CEO | 2018-06-27 | Option exercise | +43,333 | $10.69 | $463,230 | 267,689 | D |
| ROBIN HOWARD W President & CEO | 2018-06-27 | Sale | −43,333 | $47.39 | $2,053,551 | 224,356 | D |
| Derivatives | |||||||
| ROBIN HOWARD W President & CEO | 2018-06-25 | Option exercise · Stock Option | −43,334 | 126,666 | D | ||
| ROBIN HOWARD W President & CEO | 2018-06-26 | Option exercise · Stock Option | −43,333 | 83,333 | D | ||
| ROBIN HOWARD W President & CEO | 2018-06-27 | Option exercise · Stock Option | −43,333 | 40,000 | D | ||
| Open-market sales · 130,000 sh · avg $49.52 · $6,438,036 | |||||||
Loading xslF345X03/doc4.xml…